The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://charlieragg290218.wikijm.com/1954112/glp_3_receptor_agonists_retatrutide_trizepatide